Europe E-prescribing Market - Industry Outlook and Forecast 2021-2026

Europe E-prescribing Market - Industry Outlook and Forecast 2021-2026

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Europe E-Prescribing Market Report

The Europe e-prescribing market to cross over USD 1 billion, growing at a CAGR of around 23% during the forecast period.

Telehealth services are among the second biggest eHealth trends in Europe after patient electronic health records. One of the significant factors driving the industry growth is the growing awareness and acceptance of remote monitoring solutions and increasing technological advances. For example, in March 2020, Germany performed more than 19,500 teleconsultations. In Norway, the share of e-consultations was almost 60%. France is a successful example of telehealth adoption, with nearly ten years of successful telehealth legislation in place. Artificial intelligence to transform the digital prescription technology market in Europe. Big data analytics and machine learning algorithms for analyzing large-scale EMRs data are developed to understand the way prescribers treat patients automatically in real-life scenarios. For instance, AI helps prevent drug overdose by utilizing the medication history to predict the potential for opioid overdose priorly, augmenting the efforts of clinicians to detect such life-threatening risks.

The following factors are likely to contribute to the growth of the European e-prescription market during the forecast period:

  • Growing adoption of telehealth services in Europe.
  • Artificial intelligence to eradicate prescription error normalizing cross-border healthcare via new e-prescription paradigms.
  • Favourable programs for high penetration of EHR.
  • Several European countries have passed laws and implemented policies for adopting e-prescription.
The report considers the present scenario of the Europe e-prescribing market and its market dynamics for the period 2021−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.


The standard segment accounted for a share of over 94% in the Europe e-prescribing market in 2020. Standard e-prescribing system is a robust technology facilitating an interactive data transaction. These transactions in standard software allow prescribers to view a complete medication list of patients. E-prescribing enhances the efficiency and effectiveness of patient care through automated clinical decision support and tracking of complete medication profiles. Such tools can reduce patient risk towards drugs by identifying them automatically.

Cloud and web-based systems are highly preferred than on-premise as it does not require complex installation processes to set up intense infrastructure to host data. One of the major reasons for the high adoption of web-based solutions is that it can be done through the internet without IT support and minimizes additional cost. Cloud services enable the ability to access healthcare data from different locations and across multiple devices. It can access and process EHRs, collect data, and visualize diagnostic images in various resolutions.

The integrated e-prescribing solutions are in high demand and accounting for a significant share of over 88% in the modality segment. Integrated solutions can improve patient safety and communication with providers. It provides real-time, patient-centered records that are instant, secure, and accessible only by authorized users at a medical practice and provide a broad view about the care a patient has received. Vendors are increasingly focusing on adopting the integration of EHR into their e-prescribing solutions. Emerging players are offering integrated services, which is contributing to its wider acceptance.

Cardiovascular drugs are the most commonly e-prescribing medications mainly due to the fact of the increasing prevalence of cardiovascular diseases. These remain as the leading cause of mortality and a significant cause of morbidity in Europe, causing 45% of all deaths in Europe and 37% in the European Union. The medication type segment includes cardiovascular, anti-infectives, oncology, pain management, behavioral and mental health, and others. With the growing burden of various diseases, the consumption of drugs has drastically increased. E-prescription has emerged as an effective solution to control the overuse of medications and prevent adverse drug events associated with their overdose. It has successfully proven to reduce such adverse events by limiting the prescribing of drugs and monitoring their usage simultaneously.

The interest in digital health and related technologies increased rapidly in clinical medicine as well as biomedical research and drug discovery. Vendors are customizing their telehealth services by including e-prescribing. E-prescription integrated with advanced telehealth solutions can be used for routine check-ups or prescription refills. Some telehealth services are integrated with EHR to allow electronic prescription.

Segmentation by Type
  • Standard e-prescribing
  • EPCS
Segmentation by Delivery mode
  • Web & Cloud based
  • On-premise & Desktop
Segmentation by Modality
  • Integrated
  • Standalone
Segmentation by Medication
  • Cardiovascular
  • Anti-infectives
  • Oncology
  • Pain medication
  • Behavioral & mental health
  • Others

In EU-5, a growing number of healthcare organizations are actively involved in the adoption of digitized services that include eHealth, telemedicine, e-prescribing, EHRs, and others. With such advancements, EU-5 is projected to grow at a lucrative rate due to the increasing demand for EHRs and online prescribing services, favourable governmental policies, and increasing healthcare expenditures.

The rest of Europe has considerable growth potential in the e-prescribing market due to ongoing government initiatives at the country level on implementing and mandating the use of electronic prescribing of medications. Other factors such as the prevalence of chronic illness, demand for online prescriptions, increased concerns of reducing medication errors, healthcare expenditures, and adoption of EHRs for telehealth services are boosting the use of electronic prescription in the region.

Segmentation by Geography
  • EU-5
  • UK
  • Italy
  • Spain
  • Germany
  • France
  • Rest of Europe
  • Netherlands
  • Sweden
  • Denmark
  • Austria
  • Finland
  • Other

The e-prescribing market in Europe consists of some prominent players, including Surescripts, Henry Schein, Aegis Healthcare, DrChrono, SISGAIN, CarePaths, eClinicalWorks, CGI, and Change Healthcare which contributing to the growth of the market in Europe. The market is likely to witness a rise and increased competition due to the emergence of mid-sized players and start-ups after the comprehensive implementation of online prescribing services across Europe. In coming years, European countries are likely to witness high growth as favourable government initiatives will mandate electronic prescribing software.

Key Vendors
  • Surescripts
  • Henry Schein
  • Aegis Healthcare
  • DrChrono
  • CarePaths
  • eClinicalworks
  • CGI
  • Change Healthcare
Other Prominent Vendors
  • Nortal
  • Medicata

1 How big is the European e-prescribing market?

2 What is the e-prescribing market growth rate?

3 Who are the key players in the European e-prescribing market?

4 Which segment accounted for the largest ePrescribing market share?

5 What are the key driving factors for the E-Prescribing Market?

1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Type
4.3.2 Market Segmentation by Delivery Mode
4.3.3 Market Segmentation by Modality
4.3.4 Market Segmentation by Medication Type
4.3.5 Market Segmentation by End-user
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Features of an ideal e-prescribing system
7.1.2 Standards for Electronic Prescription Systems
7.1.3 State of E-prescribing in Europe
8 Market Opportunities & Trends
8.1 Growing Adoption of Telehealth Services In Europe
8.2 AI To Eradicate Prescription Errors
8.3 Normalizing Cross-Border Healthcare Via New E-Prescription Paradigms In Europe
9 Market Growth Enablers
9.1 Reducing Handwritten Prescriptions & Errors
9.2 Favorable Programs For High EHR Penetration
9.3 Initiatives For Adopting E-Prescribing In Europe
9.4 Healthcare Payors Influencing E-Prescribing Decisions
10 Market Restraints
10.1 Issues Regarding Security & Data Breach
10.2 Lack Of Standardization & Inadequate Training For Clinicians
10.3 Incompatible Software Systems & Complex Technologies
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Impact of COVID-19 in Europe
11.4 Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Standard E-Prescribing
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 EPCS
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Delivery Mode
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Web & Cloud-Based
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 On-Premise & Desktop
13.4.1 Market Overview
13.4.2 Market Size & Forecast
14 Modality
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Integrated
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Standalone
14.4.1 Market Overview
14.4.2 Market Size & Forecast
15 Medication Type
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Cardiovascular
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Anti-Infectives
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Oncology
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Pain Medication
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Behavioral & Mental Health
15.7.1 Market Overview
15.7.2 Market Size & Forecast
15.8 Others
15.8.1 Market Overview
15.8.2 Market Size & Forecast
16 End-User
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Technology Vendors
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.4 Independent & Specialty Pharmacies
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.5 Healthcare Facilities
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.6.1 Market Overview
16.6.2 Market Size & Forecast
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
18 EU-5
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 UK: Market Size & Forecast
18.3.2 Italy: Market Size & Forecast
18.3.3 Spain: Market Size & Forecast
18.3.4 Germany: Market Size & Forecast
18.3.5 France: Market Size & Forecast
19 Rest of Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Netherlands: Market Size & Forecast
19.3.2 Sweden: Market Size & Forecast
19.3.3 Denmark: Market Size & Forecast
19.3.4 Austria: Market Size & Forecast
19.3.5 Finland: Market Size & Forecast
19.3.6 Others: Market Size & Forecast
20 Competitive Landscape
20.1 Competition Overview
20.2 Market Share Analysis
20.2.1 Surescripts
20.2.2 Henry Schein
20.2.3 Aegis Healthcare
20.2.4 DrChrono
20.2.5 SISGAIN
20.2.6 CarePaths
20.2.7 eClinicalWorks
20.2.8 CGI
20.2.9 Change Healthcare
21 Key Company Profiles
21.1 Surescripts
21.1.1 Business Overview
21.1.2 Surescripts in E-prescribing Market
21.1.3 Product Offerings
21.1.4 Key Strategies
21.1.5 Key Strengths
21.1.6 Key Opportunities
21.2 Henry Schein
21.2.1 Business Overview
21.2.2 Henry Schein In E-Prescribing Market
21.2.3 Product Offerings
21.2.4 Key Strategies
21.2.5 Key Strengths
21.2.6 Key Opportunities
21.3 Aegis Healthcare
21.3.1 Business Overview
21.3.2 Aegis Healthcare in E-prescribing Market
21.3.3 Product Offerings
21.3.4 Key Strategies
21.3.5 Key Strengths
21.3.6 Key Opportunities
21.4 DrChrono
21.4.1 Business Overview
21.4.2 DrChrono in E-prescribing Market
21.4.3 Product Offerings
21.4.4 Key Strategies
21.4.5 Key Strengths
21.4.6 Key Opportunities
21.5.1 Business Overview
21.5.2 SISGAIN in E-prescribing Market
21.5.3 Product Offerings
21.5.4 Key Strategies
21.5.5 Key Strengths
21.5.6 Key Opportunities
21.6 CarePaths
21.6.1 Business Overview
21.6.2 CarePaths in E-prescribing Market
21.6.3 Product Offerings
21.6.4 Key Strategies
21.6.5 Key Strengths
21.6.6 Key Opportunities
21.7 eClinicalWorks
21.7.1 Business Overview
21.7.2 eClinicalWorks in E-prescribing Market
21.7.3 Product Offerings
21.7.4 Key Strategies
21.7.5 Key Strengths
21.7.6 Key Opportunities
21.8 CGI
21.8.1 Business Overview
21.8.2 CGI in E-prescribing Market
21.8.3 Product Offerings
21.8.4 Key Strategies
21.8.5 Key Strengths
21.8.6 Key Opportunities
21.9 Change Healthcare
21.9.1 Business Overview
21.9.2 Change Healthcare in E-prescribing Market
21.9.3 Product Offerings
21.9.4 Key Strategies
21.9.5 Key Strengths
21.9.6 Key Opportunities
22 Other Prominent Vendors
22.1 Nortal
22.1.1 Business Overview
22.1.2 Product Offerings
22.2 Medicata
22.2.1 Business Overview
22.2.2 Product Offerings
23 Report Summary
23.1 Key Takeaways
23.2 Strategic Recommendations
24 Quantitative Summary
24.1 Market By Delivery Mode
24.2 Market By Type
24.3 Market By Modality
24.4 Market Medication Type
24.5 Market By End-User
25 Appendix
25.1 Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings